Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-10.65M
↓ 24% below average
Average (2y)
$-8.57M
Historical baseline
Range
High:$-6.71M
Low:$-10.65M
CAGR
+26.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.65M | -27.5% |
| 2023 | $-8.36M | -24.5% |
| 2022 | $-6.71M | - |